Albert David Limited has announced its audited financial results for the quarter and year ended March 31, 2026, alongside the appointment of Mr. Amit Mahla as Chief Executive Officer. The Board of Directors recommended a final dividend of 50%, amounting to Rs. 5.00 per equity share of Rs. 10/- face value. For the quarter ended March 31, 2026, the company reported revenue from operations of Rs. 85.86 Crores, reflecting a 4.52% decrease from the previous quarter’s Rs. 89.93 Crores and a 14.65% increase over the Rs. 74.89 Crores recorded in the same quarter last year. The company faced a net loss of Rs. 21.43 Crores during this quarter, compared to a profit of Rs. 15.30 Crores in the preceding quarter and a loss of Rs. 10.33 Crores in the corresponding period of the previous year.

Albert David Limited, a prominent unit of the Kothari Group, is a Kolkata-based pharmaceutical company established in 1938 that specializes in manufacturing allopathic and herbal formulations, infusion solutions, and medical disposables. The company operates manufacturing facilities in Kolkata and Ghaziabad and maintains a strategic focus on segments such as vision care, parenterals, and oral formulations. Prominent institutional investors include General Insurance Corporation of India, which held a 1.61% stake as of March 2026.